Abstract
High rates of early mortality are a consistent feature of antiretroviral therapy (ART) rollout programs in Africa, despite otherwise impressive reductions in morbidity and mortality. Advanced HIV disease at treatment initiation (as reflected by low CD4-cell counts) is likely the cause of many of these deaths, but immune reconstitution inflammatory syndrome (IRIS) could also play a role. In the present study, investigators evaluated mortality rates and causes of death among 559 patients in urban Uganda (69% women) …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
